Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

di Müller, F, Stiegler, C, Hadding, U
Pubblicazione 1992

Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

di Däubener, W, Mackenzie, C, Hadding, U
Pubblicazione 1995

The ninth component of human complement: isolation, description and mode of action

di Hadding, U., Müller-Eberhard, H. J.
Pubblicazione 1969

An in vitro system to study listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns.

di Ottendorfer, D, Bitter-Suermann, D, Hadding, U
Pubblicazione 1985

Cytoadhesins of Mycoplasma hominis.

di Henrich, B, Feldmann, R C, Hadding, U
Pubblicazione 1993

Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

di Hamuro, J, Hadding, U, Bitter-Suermann, D
Pubblicazione 1978

Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.

di Kossorotow, A, Opitz, W, Etschenberg, E, Hadding, U
Pubblicazione 1977

Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

di Böttger, E C, Hoffmann, T, Hadding, U, Bitter-Suermann, D
Pubblicazione 1986

Bypass-activation of the complement system starting with C3: I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom

di Bitter-Suermann, D., Dierich, M., König, W., Hadding, U.
Pubblicazione 1972

Insoluble polyanions as activators of both pathways of complement

di Burger, R., Bitter-Suermann, D., Loos, M., Hadding, U.
Pubblicazione 1977

Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.

di Feldmann, R C, Henrich, B, Kolb-Bachofen, V, Hadding, U
Pubblicazione 1992

Clostridium difficile toxins A and B inhibit human immune response in vitro.

di Däubener, W, Leiser, E, von Eichel-Streiber, C, Hadding, U
Pubblicazione 1988

Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.

di Hartung, H P, Hadding, U, Bitter-Suermann, D, Gemsa, D
Pubblicazione 1984

Repetitive elements of the Mycoplasma hominis adhesin p50 can be differentiated by monoclonal antibodies.

di Henrich, B, Kitzerow, A, Feldmann, R C, Schaal, H, Hadding, U
Pubblicazione 1996

Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

di Burger, R, Hadding, U, Schorlemmer, H U, Brade, V, Bitter-Suermann, D
Pubblicazione 1975

Septicemia due toStreptococcus mitis in neutropenic patients with acute leukemia

di Arning, M., Gehrt, A., Aul, C., Runde, V., Hadding, U., Schneider, W.
Pubblicato in Blut (1990)

Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state.

di Mauer-Gross, U, von Steldern, D, Hadding, U, Bitter-Suermann, D, Burger, R
Pubblicazione 1985

Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

di Flegel, W A, Müller, F, Däubener, W, Fischer, H G, Hadding, U, Northoff, H
Pubblicazione 1991

Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency

di Dierich, M. P., Bitter-Suermann, D., König, W., Hadding, U., Galanos, C., Rietschel, E. T.
Pubblicazione 1973

In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

di Hoffmann, T, Böttger, E C, Baum, H P, Messner, M, Hadding, U, Bitter-Suermann, D
Pubblicazione 1988